Testosterone Cypionate
- Product NDC
- 55150-278
- 11-digit product format
- 551500278
- Labeler code
- 55150
- Product ID
- 55150-278_b622f795-00fa-48e3-8e4d-679c2ce28c6c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Testosterone Cypionate
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR
- Labeler
- Eugia US LLC
- Application
- ANDA211817
- Marketing category
- ANDA
- Marketing start
- 2023-10-20
- Substance
- TESTOSTERONE CYPIONATE
- Active strength
- 2000 mg/10mL
- Pharmacologic classes
- Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]
- DEA schedule
- CIII
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Testosterone Cypionate
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TESTOSTERONE CYPIONATE | 2000 mg/10mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | M0XW1UBI14 |
| Rxcui | 835829, 835840, 2047882 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 55150-278-01 | Testosterone Cypionate | 10 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 10 | | 3 |
| 55150-278-01 | Testosterone Cypionate | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 55150-278 | TESTOSTERONE CYPIONATE INJECTION, SOLUTION [EUGIA US LLC] | 2 | Current NDC, 2 package rows | 20250322_f901e2b2-f143-4237-8e95-0d134585490b.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 55150-278-01 | 55150027801 | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-278-01) / 10 mL in 1 VIAL, MULTI-DOSE | 2023-10-20 | No | No | Current |